2009
DOI: 10.1137/08s010323
|View full text |Cite
|
Sign up to set email alerts
|

A Mathematical Model of the Immune System's Role in Obesity-Related Chronic Inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 12 publications
0
5
0
Order By: Relevance
“…These changes can better mimic the biological interactions in an organism. Currently, models are designed to simulate the biological data only over a fixed time period 135 . There are no data for extended time spans available to validate the models.…”
Section: Conclusion and Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…These changes can better mimic the biological interactions in an organism. Currently, models are designed to simulate the biological data only over a fixed time period 135 . There are no data for extended time spans available to validate the models.…”
Section: Conclusion and Discussionmentioning
confidence: 99%
“…Drug response to a host’s immune system can be better studied through computational models. The effect of drug administration can be added to model the immune system to find the drug efficacy 135 …”
Section: Conclusion and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, many other signaling mechanisms could affect the efficacy of vascular-targeted therapies, like the competition between pro- and anti-angiogenic VEGF-A isoforms, cross-family PDGF-VEGFR2 signaling, and paracrine signaling between the endothelium and adipocytes/macrophages, as we detailed earlier. To more accurately predict how obese adipose tissue responds to vascular-targeted therapies, future models should integrate the ODEs that have been developed to model: the impact of VEGFR heterogeneity on anti-VEGF efficacy ( Weddell and Imoukhuede, 2014 ) the differential VEGF signal transduction by VEGFR homo- and hetero-dimers ( Mac Gabhann and Popel, 2007 ; Mamer et al, 2019b ), the significance of VEGF-A 165b in ischemic conditions ( Chu et al, 2016 ; Clegg et al, 2017 ), the effect of cross-family PDGF-VEGFR binding on VEGFR occupancy ( Mamer et al, 2017 ), the VEGFR mechanisms inducing macrophage migration ( Weddell et al, 2018 ), the recruitment of macrophages to the lymphatic endothelium ( Bianchi et al, 2015 ), and the pro- and anti-inflammatory signaling of adipose tissue macrophages ( Díaz et al, 2009 ). Modeling these molecules, interactions, and cell responses would allow us to determine which mechanisms in adipose tissue could be targeted to normalize VEGF:VEGFR signaling in obesity.…”
Section: Systems Biology Provides a Platform For Investigating Vasculmentioning
confidence: 99%